
### [MONDO:0016677](http://purl.obolibrary.org/obo/MONDO_0016677)
**Label:** toxic or drug-related embryofetopathy

**Subclasses:** [MONDO:0016005](http://purl.obolibrary.org/obo/MONDO_0016005) (indomethacin embryofetopathy), [MONDO:0016467](http://purl.obolibrary.org/obo/MONDO_0016467) (Isotretinoin syndrome), [MONDO:0016016](http://purl.obolibrary.org/obo/MONDO_0016016) (Toluene embryopathy), [MONDO:0009272](http://purl.obolibrary.org/obo/MONDO_0009272) (german syndrome), [MONDO:0016015](http://purl.obolibrary.org/obo/MONDO_0016015) (Phenobarbital embryopathy), [MONDO:0016004](http://purl.obolibrary.org/obo/MONDO_0016004) (aminopterin/methotrexate embryofetopathy), [MONDO:0016007](http://purl.obolibrary.org/obo/MONDO_0016007) (cocaine embryofetopathy), [MONDO:0016017](http://purl.obolibrary.org/obo/MONDO_0016017) (Methimazole embryofetopathy), [MONDO:0016012](http://purl.obolibrary.org/obo/MONDO_0016012) (Diethylstilbestrol syndrome), [MONDO:0016011](http://purl.obolibrary.org/obo/MONDO_0016011) (fetal alcohol syndrome), [MONDO:0018442](http://purl.obolibrary.org/obo/MONDO_0018442) (Acitretin/etretinate embryopathy), [MONDO:0016014](http://purl.obolibrary.org/obo/MONDO_0016014) (fetal minoxidil syndrome), [MONDO:0012275](http://purl.obolibrary.org/obo/MONDO_0012275) (fetal valproate syndrome), [MONDO:0016013](http://purl.obolibrary.org/obo/MONDO_0016013) (fetal methylmercury syndrome), [MONDO:0009224](http://purl.obolibrary.org/obo/MONDO_0009224) (fetal iodine syndrome), [MONDO:0018034](http://purl.obolibrary.org/obo/MONDO_0018034) (thalidomide embryopathy), [MONDO:0018262](http://purl.obolibrary.org/obo/MONDO_0018262) (fetal anticonvulsant syndrome), [MONDO:0017055](http://purl.obolibrary.org/obo/MONDO_0017055) (Mycophenolate mofetil embryopathy), [MONDO:0016010](http://purl.obolibrary.org/obo/MONDO_0016010) (vitamin K-antagonist embryofetopathy), [MONDO:0018263](http://purl.obolibrary.org/obo/MONDO_0018263) (fetal carbamazepine syndrome), [MONDO:0016009](http://purl.obolibrary.org/obo/MONDO_0016009) (fetal trimethadione syndrome), [MONDO:0016008](http://purl.obolibrary.org/obo/MONDO_0016008) (fetal hydantoin syndrome), 

**Corr. equiv. classes:** [Orphanet:1909](http://www.orpha.net/ORDO/Orphanet_1909), [Orphanet:1908](http://www.orpha.net/ORDO/Orphanet_1908), [Orphanet:1906](http://www.orpha.net/ORDO/Orphanet_1906), [Orphanet:1914](http://www.orpha.net/ORDO/Orphanet_1914), [OMIM:231080](http://purl.obolibrary.org/obo/OMIM_231080), [Orphanet:1913](http://www.orpha.net/ORDO/Orphanet_1913), [Orphanet:370068](http://www.orpha.net/ORDO/Orphanet_370068), [Orphanet:1912](http://www.orpha.net/ORDO/Orphanet_1912), [Orphanet:1911](http://www.orpha.net/ORDO/Orphanet_1911), [Orphanet:1910](http://www.orpha.net/ORDO/Orphanet_1910), [Orphanet:3312](http://www.orpha.net/ORDO/Orphanet_3312), [Orphanet:2305](http://www.orpha.net/ORDO/Orphanet_2305), [Orphanet:1919](http://www.orpha.net/ORDO/Orphanet_1919), [Orphanet:1918](http://www.orpha.net/ORDO/Orphanet_1918), [Orphanet:1917](http://www.orpha.net/ORDO/Orphanet_1917), [Orphanet:1916](http://www.orpha.net/ORDO/Orphanet_1916), [Orphanet:1915](http://www.orpha.net/ORDO/Orphanet_1915), [OMIM:228355](http://purl.obolibrary.org/obo/OMIM_228355), [Orphanet:40366](http://www.orpha.net/ORDO/Orphanet_40366), [Orphanet:2077](http://www.orpha.net/ORDO/Orphanet_2077), [Orphanet:268249](http://www.orpha.net/ORDO/Orphanet_268249), [Orphanet:370076](http://www.orpha.net/ORDO/Orphanet_370076), [Orphanet:1923](http://www.orpha.net/ORDO/Orphanet_1923), [OMIM:609442](http://purl.obolibrary.org/obo/OMIM_609442), [Orphanet:1920](http://www.orpha.net/ORDO/Orphanet_1920), 

**Class expressions from DL-Learner:**

- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 46.39%
- Thing 46.38%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 46.38%
- [HP:0000152](http://purl.obolibrary.org/obo/HP_0000152) (Abnormality of head or neck) 34.99%
- [HP:0000924](http://purl.obolibrary.org/obo/HP_0000924) (Abnormality of the skeletal system) 34.91%
- [HP:0000598](http://purl.obolibrary.org/obo/HP_0000598) (Abnormality of the ear) 34.05%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) 32.64%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) 31.56%
- [HP:0001507](http://purl.obolibrary.org/obo/HP_0001507) (Growth abnormality) 25.11%
- [HP:0040064](http://purl.obolibrary.org/obo/HP_0040064) (Abnormality of limbs) 24.97%
- [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) 24.96%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) 24.68%
- [HP:0000119](http://purl.obolibrary.org/obo/HP_0000119) (Abnormality of the genitourinary system) 23.04%
- [HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument) 22.72%
- [HP:0003549](http://purl.obolibrary.org/obo/HP_0003549) (Abnormality of connective tissue) 17.34%


